Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma.
Ribeiro MFSA, Gadotti LL, Sacardo KP, Lopes CDH, Saddi R, Alessi JVM, de Macedo MP, do Nascimento ECT, Testagrossa LA, Katz A.
Ribeiro MFSA, et al. Among authors: testagrossa la.
SAGE Open Med Case Rep. 2022 May 21;10:2050313X221100407. doi: 10.1177/2050313X221100407. eCollection 2022.
SAGE Open Med Case Rep. 2022.
PMID: 35619747
Free PMC article.